ÂÜŔňÂŇÂ×

Alex is founder, CEO and Portfolio Manager of Reneo Capital Management LP. A successful healthcare investor and executive, Alex brings more than 20 years of experience shaping and advising biopharmaceutical companies. Prior to forming Reneo, he served in roles including Chief Financial Officer of Sophiris Bio and Vice President of Finance of Amylin Pharmaceuticals. Previously, he served as a board member for Ignyta; and he ran Casdin Advisors LLC, providing strategic advice to life science companies, including Amylin. Before founding Casdin Advisors, Alex was Chief Executive Officer and Portfolio Manager of Cooper Hill Partners LLC, a healthcare investment fund, and before that, as Portfolio Manager of Pequot Capital Management’s healthcare fund. Earlier, Alex worked at the Dreyfus Corporation as a Senior Managing Analyst covering pharmaceuticals, biotechnology and medical devices. He also served as a Legislative Assistant to Congressman Robert J. Mrazek (D-NY) and then as Legislative Affairs Specialist for Patton Boggs LLP in Washington, D.C. He currently serves as an Advisor to Luna DNA, a Board Member of DiaVacs and an Advisory Board Member of MD Revolution. He also is a Board Member of The Conquer Cancer Foundation of the American Society of Clinical Oncology, a member of the Advisory Board of the Social Enterprise Program at Columbia Business School, a member of the External Advisory Board for the Center for Biomedical Engineering at Brown University’s School of Engineering, and a member of Brown’s President’s Leadership Council. He also serves on the Advisory Board of the Hassenfeld Children’s Center for Pediatric Oncology and Blood Disorders at NYU Langone Medical Center. Alex holds an A.B. in Political Science from Brown University and an M.B.A., Beta Gamma Sigma, from Columbia Business School.